Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 4/2007

01-12-2007 | Original article

The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab

Authors: Francesca Di Fabio, Carmine Pinto, Fabiola L. Rojas Llimpe, Stefano Fanti, Paolo Castellucci, Ciro Longobardi, Vita Mutri, Chiara Funaioli, Francesca Sperandi, Stefania Giaquinta, Andrea A. Martoni

Published in: Gastric Cancer | Issue 4/2007

Login to get access
Metadata
Title
The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab
Authors
Francesca Di Fabio
Carmine Pinto
Fabiola L. Rojas Llimpe
Stefano Fanti
Paolo Castellucci
Ciro Longobardi
Vita Mutri
Chiara Funaioli
Francesca Sperandi
Stefania Giaquinta
Andrea A. Martoni
Publication date
01-12-2007
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 4/2007
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-007-0438-3

Other articles of this Issue 4/2007

Gastric Cancer 4/2007 Go to the issue

Original article

Changes in vitamin D after gastrectomy

Review article

Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives

Case report

Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer

Original article

Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer

Original article

Surgeons' knowledge of quality indicators for gastric cancer surgery

Case report

Recurrence of gastric cancer in the jejunal pouch after completion gastrectomy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits